AU2013317899A1 - Biodegradable microcapsules containing filling material - Google Patents

Biodegradable microcapsules containing filling material Download PDF

Info

Publication number
AU2013317899A1
AU2013317899A1 AU2013317899A AU2013317899A AU2013317899A1 AU 2013317899 A1 AU2013317899 A1 AU 2013317899A1 AU 2013317899 A AU2013317899 A AU 2013317899A AU 2013317899 A AU2013317899 A AU 2013317899A AU 2013317899 A1 AU2013317899 A1 AU 2013317899A1
Authority
AU
Australia
Prior art keywords
composition
microcapsules
therapeutic agent
shell
filling material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2013317899A
Other languages
English (en)
Other versions
AU2013317899A8 (en
Inventor
Kinam Park
Christopher A. Rhodes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akina Inc
OHR Pharma LLC
Original Assignee
Akina Inc
OHR Pharma LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akina Inc, OHR Pharma LLC filed Critical Akina Inc
Publication of AU2013317899A1 publication Critical patent/AU2013317899A1/en
Publication of AU2013317899A8 publication Critical patent/AU2013317899A8/en
Priority to AU2018204552A priority Critical patent/AU2018204552A1/en
Priority to AU2020202735A priority patent/AU2020202735A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Dermatology (AREA)
AU2013317899A 2012-09-20 2013-09-20 Biodegradable microcapsules containing filling material Abandoned AU2013317899A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2018204552A AU2018204552A1 (en) 2012-09-20 2018-06-22 Biodegradable Microcapsules Containing Filling Material
AU2020202735A AU2020202735A1 (en) 2012-09-20 2020-04-23 Biodegradable Microcapsules Containing Filling Material

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261703723P 2012-09-20 2012-09-20
US61/703,723 2012-09-20
PCT/US2013/060922 WO2014047439A1 (en) 2012-09-20 2013-09-20 Biodegradable microcapsules containing filling material

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2018204552A Division AU2018204552A1 (en) 2012-09-20 2018-06-22 Biodegradable Microcapsules Containing Filling Material

Publications (2)

Publication Number Publication Date
AU2013317899A1 true AU2013317899A1 (en) 2015-05-07
AU2013317899A8 AU2013317899A8 (en) 2015-05-28

Family

ID=50341971

Family Applications (3)

Application Number Title Priority Date Filing Date
AU2013317899A Abandoned AU2013317899A1 (en) 2012-09-20 2013-09-20 Biodegradable microcapsules containing filling material
AU2018204552A Abandoned AU2018204552A1 (en) 2012-09-20 2018-06-22 Biodegradable Microcapsules Containing Filling Material
AU2020202735A Abandoned AU2020202735A1 (en) 2012-09-20 2020-04-23 Biodegradable Microcapsules Containing Filling Material

Family Applications After (2)

Application Number Title Priority Date Filing Date
AU2018204552A Abandoned AU2018204552A1 (en) 2012-09-20 2018-06-22 Biodegradable Microcapsules Containing Filling Material
AU2020202735A Abandoned AU2020202735A1 (en) 2012-09-20 2020-04-23 Biodegradable Microcapsules Containing Filling Material

Country Status (9)

Country Link
US (3) US20150265541A1 (enExample)
EP (1) EP2897593A4 (enExample)
JP (2) JP2015532928A (enExample)
KR (1) KR20150090038A (enExample)
AU (3) AU2013317899A1 (enExample)
BR (1) BR112015006087A2 (enExample)
HK (1) HK1214127A1 (enExample)
MX (2) MX2015003665A (enExample)
WO (1) WO2014047439A1 (enExample)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011106702A2 (en) 2010-02-25 2011-09-01 The Johns Hopkins University Sustained delivery of therapeutic agents to an eye compartment
WO2012039979A2 (en) 2010-09-10 2012-03-29 The Johns Hopkins University Rapid diffusion of large polymeric nanoparticles in the mammalian brain
WO2012109363A2 (en) 2011-02-08 2012-08-16 The Johns Hopkins University Mucus penetrating gene carriers
AU2013209452B2 (en) 2012-01-19 2015-11-05 The Johns Hopkins University Nanoparticle formulations with enhanced mucosal penetration
HK1206270A1 (en) 2012-03-16 2016-01-08 The Johns Hopkins University Controlled release formulations for the delivery of hif-1 inhibitors
US10159743B2 (en) 2012-03-16 2018-12-25 The Johns Hopkins University Non-linear multiblock copolymer-drug conjugates for the delivery of active agents
WO2013166408A1 (en) 2012-05-03 2013-11-07 Kala Pharmaceuticals, Inc. Pharmaceutical nanoparticles showing improved mucosal transport
JP6360039B2 (ja) 2012-05-03 2018-07-18 カラ ファーマシューティカルズ インコーポレイテッド 複数の被覆された粒子を含む組成物、医薬組成物、医薬製剤、及び当該粒子の形成方法
US9827191B2 (en) 2012-05-03 2017-11-28 The Johns Hopkins University Compositions and methods for ophthalmic and/or other applications
US11596599B2 (en) 2012-05-03 2023-03-07 The Johns Hopkins University Compositions and methods for ophthalmic and/or other applications
WO2013166498A1 (en) 2012-05-04 2013-11-07 The Johns Hopkins University Lipid-based drug carriers for rapid penetration through mucus linings
WO2014124006A1 (en) 2013-02-05 2014-08-14 The Johns Hopkins University Nanoparticles for magnetic resonance imaging tracking and methods of making and using thereof
WO2015127368A1 (en) 2014-02-23 2015-08-27 The Johns Hopkins University Hypotonic microbicidal formulations and methods of use
KR20170106460A (ko) 2015-01-27 2017-09-20 더 존스 홉킨스 유니버시티 점막표면에서 활성제의 향상된 수송을 위한 저장성 하이드로겔 제제
WO2017035408A1 (en) 2015-08-26 2017-03-02 Achillion Pharmaceuticals, Inc. Compounds for treatment of immune and inflammatory disorders
AR106018A1 (es) 2015-08-26 2017-12-06 Achillion Pharmaceuticals Inc Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos
US20170273911A1 (en) * 2016-03-23 2017-09-28 Boston Scientific Scimed Inc. Injectable microspheres
EP3454856B1 (en) 2016-05-10 2024-09-11 C4 Therapeutics, Inc. Heterocyclic degronimers for target protein degradation
EP3455218A4 (en) 2016-05-10 2019-12-18 C4 Therapeutics, Inc. C3 CARBON-BASED GLUTARIMIDE DEGRONIMERS FOR TARGET PROTEIN REDUCTION
WO2017197051A1 (en) 2016-05-10 2017-11-16 C4 Therapeutics, Inc. Amine-linked c3-glutarimide degronimers for target protein degradation
WO2017197036A1 (en) 2016-05-10 2017-11-16 C4 Therapeutics, Inc. Spirocyclic degronimers for target protein degradation
JP7057290B2 (ja) 2016-06-27 2022-04-19 アキリオン ファーマシューティカルズ，インコーポレーテッド 医学的障害を治療するためのキナゾリン及びインドール化合物
WO2018005860A1 (en) 2016-07-01 2018-01-04 G1 Therapeutics, Inc. Pyrimidine-based antiproliferative agents
BR112019008475B1 (pt) * 2016-10-28 2022-06-07 Unilever Ip Holdings B.V. Composição para a higiene pessoal
CN109890363A (zh) 2016-10-28 2019-06-14 荷兰联合利华有限公司 包含表面改性颗粒和非挥发性官能化硅酮的个人护理组合物
DK3985002T3 (da) 2017-03-01 2025-08-18 Achillion Pharmaceuticals Inc Farmaceutiske aryl-, heteroaryl- og heterocyclylforbindelser til behandling af medicinske forstyrrelser
CN110769822A (zh) 2017-06-20 2020-02-07 C4医药公司 用于蛋白降解的n/o-连接的降解决定子和降解决定子体
WO2019191112A1 (en) 2018-03-26 2019-10-03 C4 Therapeutics, Inc. Cereblon binders for the degradation of ikaros
JP7538113B2 (ja) 2018-08-20 2024-08-21 アキリオン ファーマシューティカルズ，インコーポレーテッド 補体ｄ因子の医学的障害の治療のための医薬化合物
WO2020051532A2 (en) 2018-09-06 2020-03-12 Achillion Pharmaceuticals, Inc. Macrocyclic compounds for the treatment of medical disorders
CN113365617B (zh) 2018-10-16 2025-12-23 乔治亚州立大学研究基金会股份有限公司 用于医学疾病治疗的一氧化碳前药
WO2020149684A2 (ko) * 2019-01-18 2020-07-23 주식회사 대하맨텍 인체에 자극이 없어 안전하고 생분해가 가능한 캡슐 및 그의 제조방법
KR102272566B1 (ko) * 2019-01-18 2021-07-05 주식회사 대하맨텍 인체에 자극이 없어 안전하고 생분해가 가능한 캡슐 및 그의 제조방법
FR3091878B1 (fr) 2019-01-22 2023-06-16 Calyxia Compositions de produits d’entretien avec des propriétés olfactives améliorées
FR3091877B1 (fr) 2019-01-22 2023-06-16 Calyxia Compositions de detergence avec des propriétés olfactives améliorées
WO2020210805A1 (en) 2019-04-11 2020-10-15 The Johns Hopkins University Nanoparticles for drug delivery to brain
EA202192738A1 (ru) 2019-04-12 2022-03-17 С4 Терапьютикс, Инк. Трициклические соединения, обеспечивающие разрушение белка ikaros и белка aiolos
JP2023515073A (ja) 2020-02-20 2023-04-12 アキリオン ファーマシューティカルズ， インコーポレーテッド 補体因子ｄ媒介障害の処置用のヘテロアリール化合物
CN115279370B (zh) 2020-03-05 2025-01-10 C4医药公司 用于brd9的靶向降解的化合物
EP4652997A2 (en) 2020-05-19 2025-11-26 Pharmacosmos Holding A/s Cyclin-dependent kinase inhibiting compounds for the treatment of medical disorders
JP7787164B2 (ja) 2020-09-23 2025-12-16 アキリオン ファーマシューティカルズ， インコーポレーテッド 補体媒介性障害の治療のための医薬化合物
WO2024184188A1 (en) * 2023-03-03 2024-09-12 Danmarks Tekniske Universitet A method for preparing microparticles for drug delivery

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001388A (en) * 1973-06-14 1977-01-04 Alza Corporation Ophthalmological bioerodible drug dispensing formulation
US4865846A (en) * 1988-06-03 1989-09-12 Kaufman Herbert E Drug delivery system
AU2001298061A1 (en) * 2000-12-13 2003-07-09 Purdue Research Foundation Microencapsulation of drugs by solvent exchange
US8425929B2 (en) * 2004-04-30 2013-04-23 Allergan, Inc. Sustained release intraocular implants and methods for preventing retinal dysfunction
JP2008520547A (ja) * 2004-10-04 2008-06-19 キューエルティー ユーエスエー，インコーポレイテッド． 眼部送達のためのポリマー送達処方
JP4856881B2 (ja) * 2005-02-01 2012-01-18 川澄化学工業株式会社 薬剤徐放システム
JP2009507845A (ja) * 2005-09-07 2009-02-26 サウスウエスト リサーチ インスティテュート 改良された放出速度を示す生分解性微粒子薬学的処方物
JP5201763B2 (ja) * 2007-02-28 2013-06-05 昇一 城武 異なる平均粒径サイズの粒子からなる混合微粒子カプセルの製造方法
US8071119B2 (en) * 2007-05-14 2011-12-06 Sustained Nano Systems Llc Controlled release implantable dispensing device and method
US8951567B2 (en) * 2007-09-27 2015-02-10 Akina, Inc. Sol-gel phase-reversible hydrogel templates and uses thereof
US20130316010A1 (en) * 2010-10-18 2013-11-28 Case Western Reserve University Polymeric microparticles

Also Published As

Publication number Publication date
MX2019002575A (es) 2019-10-30
KR20150090038A (ko) 2015-08-05
BR112015006087A2 (pt) 2017-07-04
JP2015532928A (ja) 2015-11-16
MX2015003665A (es) 2016-03-08
US20150265541A1 (en) 2015-09-24
WO2014047439A1 (en) 2014-03-27
HK1214127A1 (zh) 2016-10-07
EP2897593A1 (en) 2015-07-29
AU2018204552A1 (en) 2018-07-12
EP2897593A4 (en) 2016-04-06
US20180185296A1 (en) 2018-07-05
JP2019014729A (ja) 2019-01-31
US20200390715A1 (en) 2020-12-17
AU2020202735A1 (en) 2020-05-14
AU2013317899A8 (en) 2015-05-28

Similar Documents

Publication Publication Date Title
US20200390715A1 (en) Biodegradable Microcapsules Containing Filling Material
Naraharisetti et al. Gentamicin-loaded discs and microspheres and their modifications: characterization and in vitro release
Pacheco et al. Development of an injectable PHBV microparticles-GG hydrogel hybrid system for regenerative medicine
EP2696851B1 (en) Multilayer thin film drug delivery device
JP5693623B2 (ja) 生物活性薬剤を含有するポリマーを含む医療用デバイスおよび方法
US11213490B2 (en) Encapsulation-free controlled protein release system
JP2008520783A (ja) ヒドロゲルマトリックスおよびマイクロキャリアを含む活性物質供給システム
WO2013119183A1 (en) Methods of manufacturing core-shell microparticles, and microparticles formed thereof
Klose et al. Unintended potential impact of perfect sink conditions on PLGA degradation in microparticles
Rodríguez-Contreras et al. Methods for the preparation of doxycycline-loaded phb micro-and nano-spheres
Iswandana et al. Formulation of chitosan tripolyphosphate-tetrandrine beads using ionic gelation method: in vitro and in vivo evaluation
Singh et al. Effect of modifications in poly (lactide-co-glycolide)(PLGA) on drug release and degradation characteristics: a mini review
CN102489230A (zh) 一种生物可降解聚合物微囊的制备方法
Le et al. Penta-block copolymer microspheres: Impact of polymer characteristics and process parameters on protein release
Wischke et al. Degradable polymeric carriers for parenteral controlled drug delivery
AU2020202040A1 (en) Multilayer Biodegradable Microparticles For Sustained Release of Therapeutic Agents
Zhang et al. Injectable biodegradable microchamber array films for long-term delivery of glucocorticoids
CN108567762B (zh) 乳酸基聚合物圆盘状载药微粒与缓释制剂及其制备方法
CN103599075A (zh) 聚乙二醇—聚乳酸包载倍他米松二丙酸酯的缓释微球及其制备方法
Thananukul et al. Fabrication of functional micro-/nano-particles from biodegradable polymers and their use in cosmetic and biomedical applications
US20080305175A1 (en) Micro-Container
Tian et al. The vitro and vivo study of Poly (3-hydroxybutyrate) microspheres
CN121177203A (zh) 一种用于内耳局部释药水凝胶及其制备方法
Faisant et al. Development of 5-FU-loaded PLGA microparticles for the treatment of glioblastoma
Bhatt et al. Effect of processing variables in formulation and development of biodegradable microparticles

Legal Events

Date Code Title Description
TH Corrigenda

Free format text: IN VOL 29 , NO 17 , PAGE(S) 2501 UNDER THE HEADING PCT APPLICATIONS THAT HAVE ENTERED THE NATIONAL PHASE - NAME INDEX UNDER THE NAME AKINA, INC., APPLICATION NO. 2013317899, UNDER INID (71) ADD CO-APPLICANT OHR PHARMA, LLC.

MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted